高速シークエンサーを用いたＨＴＬＶ－１クローナリティー解析
| Project/Area Number |
12J06916
|
|---|
| Research Category |
Grant-in-Aid for JSPS Fellows
|
| Allocation Type | Single-year Grants |
|---|
| Section | 国内 |
|---|
| Research Field |
Virology
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
フィルジ サナーズ (2014) 東京大学, 新領域創成科学研究科, 特別研究員(DC1)
FIROUZI Sanaz (2013) 東京大学, 大学院新領域創成科学研究科, 特別研究員(DC1)
FIROUZI Sanaz (2012) 東京大学, 大学院・新領域創成科学研究科, 特別研究員(DC1)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2014: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2013: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2012: ¥900,000 (Direct Cost: ¥900,000)
|
|---|
| Keywords | HTLV-1 / adult T-cell leukemia / NGS technology / HTLV-1 integration sites / HTLV-1-Clonality / in- silico analysis / absolute size of clones / JSPFAD / 成人T細胞白血病(ATL) / HTLV-1ウイルス / クローナリティー解析 / Integration site 解析 / 次世代シークエンサー / Validation of Methodology / Integration site解析 |
|---|
| Outline of Annual Research Achievements |
We took advantage of NGS technology, a unique tag system, and an original in- silico analysis pipeline to develop and internally validate a new high-throughput methodology, which enables specific isolation of HTLV-1 integration sites, and an accurate measurement of the absolute size of clones from various kinds of clinical samples even those with very low PVLs [Firouzi et al. Genome medicine 2014]. In addition, we have started analyzing clinical samples with different disease status and PVLs. We could find differing clonality patterns specific to asymptomatic carriers (ACs) and different subtypes of ATL. Hence we proposed that HTLV-1-infected individuals may be classifiable into different groups, based on their clonality patterns, ultimately affecting their diagnosis and choice of therapy. Moreover, in a cohort study, we monitored rare sets of sequential clinical samples including: samples with no change in their clinical status, and those who progressed to a more advance clinical state, as well as patients before and after medical therapy. Our initial data showed that the changes in the clonal composition of infected individuals appear to be a beneficial prognostic indicator for early detection of ATL onset. Taken together, the realization of potential applications of our methodology may have far-reaching impacts on the diagnosis, prognosis, and clinical decision-making for treatment of infected individuals. Thus, a larger scale cohort study to evaluate the clonal composition of infected cells is currently in progress.
|
| Research Progress Status |
26年度が最終年度であるため、記入しない。
|
| Strategy for Future Research Activity |
26年度が最終年度であるため、記入しない。
|
Report
(3 results)
Research Products
(12 results)
-
[Journal Article] Identification of TL-Om1, an ATL Cell Line, as a Reference Material for Human T-Lymphotropic Virus 1 Quantitative PCR.2015
Author(s)
Kuramitsu M, Okuma K, Yamagishi M, Yamochi T, Firouzi S, Momose H, Mizukami T, Takizawa K, Araki K, Sugamura K, Yamaguchi K, Watanabe T, Hamaguchi I.
-
Journal Title
Journal of Clinical Microbiology
Volume: 53
Issue: 2
Pages: 587-596
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
